LogicBio Therapeutics (NASDAQ: LOGC)

LogicBio Therapeutics Return vs. S&P

LogicBio Therapeutics Company Info

LogicBio develops gene therapy vectors for previously incurable genetic and infectious diseases. It is committed to delivering genetic medicine to pediatric patients with rare diseases. Their proprietary technology based on the non-pathogenic adeno-associated viral vector offers superior efficiency and safety compared to all competitors on the market and is uniquely suited for the treatment of children as well as adults.

Valuation